These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11402447)

  • 41. Large in-frame deletions of the rod-shaped domain of the dystrophin gene resulting in severe phenotype.
    Nevo Y; Muntoni F; Sewry C; Legum C; Kutai M; Harel S; Dubowitz V
    Isr Med Assoc J; 2003 Feb; 5(2):94-7. PubMed ID: 12674656
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel cryptic exon in intron 3 of the dystrophin gene was incorporated into dystrophin mRNA with a single nucleotide deletion in exon 5.
    Suminaga R; Takeshima Y; Adachi K; Yagi M; Nakamura H; Matsuo M
    J Hum Genet; 2002; 47(4):196-201. PubMed ID: 12166656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deletion analysis of the dystrophin gene in Duchenne and Becker muscular dystrophy patients: use in carrier diagnosis.
    Kumari D; Mital A; Gupta M; Goyle S
    Neurol India; 2003 Jun; 51(2):223-6. PubMed ID: 14571009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The sequences of intron 50 and 51 of DMD gene and the deletion mechanism of 51st exon].
    Sheng W; Chai J; Liu Z
    Zhonghua Yi Xue Za Zhi; 1996 Nov; 76(11):852-4. PubMed ID: 9275539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening for minor changes in the distal part of the human dystrophin gene in Greek DMD/BMD patients.
    Kekou K; Mavrou A; Florentin L; Youroukos S; Zafiriou DI; Skouteli HN; Metaxotou C
    Eur J Hum Genet; 1999; 7(2):179-87. PubMed ID: 10196701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The evolution of an intron: analysis of a long, deletion-prone intron in the human dystrophin gene.
    McNaughton JC; Hughes G; Jones WA; Stockwell PA; Klamut HJ; Petersen GB
    Genomics; 1997 Mar; 40(2):294-304. PubMed ID: 9119397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Muscle type promoter and its first intron abnormalities in dystrophin gene in patients with Duchenne muscular dystrophy.
    Kimura S; Fujishita S; Ikezawa M; Ogawa M; Abe K; Miike T
    J Child Neurol; 1998 Jun; 13(6):290-2. PubMed ID: 9660515
    [No Abstract]   [Full Text] [Related]  

  • 48. DGGE-based whole-gene mutation scanning of the dystrophin gene in Duchenne and Becker muscular dystrophy patients.
    Hofstra RM; Mulder IM; Vossen R; de Koning-Gans PA; Kraak M; Ginjaar IB; van der Hout AH; Bakker E; Buys CH; van Ommen GJ; van Essen AJ; den Dunnen JT
    Hum Mutat; 2004 Jan; 23(1):57-66. PubMed ID: 14695533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patterns of deletions of the dystrophin gene in different European populations.
    Danieli GA; Mioni F; Müller CR; Vitiello L; Mostacciuolo ML; Grimm T
    Hum Genet; 1993 May; 91(4):342-6. PubMed ID: 8099058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 242 breakpoints in the 200-kb deletion-prone P20 region of the DMD gene are widely spread.
    Blonden LA; Grootscholten PM; den Dunnen JT; Bakker E; Abbs S; Bobrow M; Boehm C; van Broeckhoven C; Baumbach L; Chamberlain J
    Genomics; 1991 Jul; 10(3):631-9. PubMed ID: 1679746
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Carrier genetic diagnosis of intron and/or exon-deletion Duchenne muscular dystrophy by microsatellite analysis and quantitative polymerase chain reaction].
    Huang W; Zhang C; Xie YM; Chen SL; Zhang WX; Yao XL; Zeng Y; Lu XL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):72-5. PubMed ID: 17285549
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Becker muscular dystrophy with r(X) carrying an out-of-frame DMD deletion.
    Lee KA; Han SH; Choi JR; Chung JS; Choi YC
    Pediatr Neurol; 2008 Aug; 39(2):129-32. PubMed ID: 18639760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro.
    Thi Tran HT; Takeshima Y; Surono A; Yagi M; Wada H; Matsuo M
    Mol Genet Metab; 2005 Jul; 85(3):213-9. PubMed ID: 15979033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy.
    Yagi M; Takeshima Y; Wada H; Nakamura H; Matsuo M
    Hum Genet; 2003 Feb; 112(2):164-70. PubMed ID: 12522557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening of dystrophin gene deletions in Malaysian patients with Duchenne muscular dystrophy.
    Marini M; Salmi AA; Watihayati MS; SMardziah MD; Zahri MK; Hoh BP; Ankathil R; Lai PS; Zilfalil BA
    Med J Malaysia; 2008 Mar; 63(1):31-4. PubMed ID: 18935728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
    J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Follow-up of three patients with a large in-frame deletion of exons 45-55 in the Duchenne muscular dystrophy (DMD) gene.
    Nakamura A; Yoshida K; Fukushima K; Ueda H; Urasawa N; Koyama J; Yazaki Y; Yazaki M; Sakai T; Haruta S; Takeda S; Ikeda S
    J Clin Neurosci; 2008 Jul; 15(7):757-63. PubMed ID: 18261911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation of laboratory and clinical findings with the location of Xp21 deletion in Duchenne muscular dystrophy.
    Taşdemir HA; Topaloğlu H; Dinçer P; Göğüş S; Kotiloğlu E; Ozdirim E; Yalaz K
    Turk J Pediatr; 1997; 39(3):317-24. PubMed ID: 9339110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deletion analysis and clinical correlations in patients with Xp21 linked muscular dystrophy.
    Ulgenalp A; Giray O; Bora E; Hizli T; Kurul S; Sağin-Saylam G; Karasoy H; Uran N; Dizdarer G; Tütüncüoğlu S; Dirik E; Ozkinay F; Erçal D
    Turk J Pediatr; 2004; 46(4):333-8. PubMed ID: 15641267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Re-evaluation of reading frame-shift hypothesis in Duchenne and Becker muscular dystrophy.
    Pandey GS; Kesari A; Mukherjee M; Mittal RD; Mittal B
    Neurol India; 2003 Sep; 51(3):367-9. PubMed ID: 14652441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.